Todays decision by the FDA offers hope for the millions of adults living with both conditions and provides an additional treatment option, representing a significant advancement for my patients. The FDA initially approved Ozempic in 2017 to improve blood sugar (glucose), along with diet and exercise, in adults with type 2 diabetes
Anorgasmia following initiation of GLP-1 agonist
While GLP-1 agonists have been shown to have central nervous system action, another possible mechanism is slowed gastric emptying 32,33,34 , which could increase fullness and reduce alcohol consumption
science calls it the thermic effect of food, and researchers say it increases linearly with caloric intake, independent of leanness or obesity. Put simply, the more you eat, the more heat you produce processing that food
However, like all medications, semaglutide may cause side effects, one of the most frequently discussed being diarrhea